95 related articles for article (PubMed ID: 20832529)
1. Time of occurrence of kidney acute antibody-mediated allograft rejection/acute cellular rejection and cell senescence: implications for function outcome.
Arvizu-Hernández M; Morales-Buenrostro LE; Vilatoba-Chapa M; Mancilla-Urrea E; Uribe-Uribe N; Avila-Casado MC; de Leo C; Arvizu A; Gonzalez JL; Torres J; Gabilondo B; Correa-Rotter R; Alberú J
Transplant Proc; 2010 Sep; 42(7):2486-92. PubMed ID: 20832529
[TBL] [Abstract][Full Text] [Related]
2. Differential outcomes in 3 types of acute antibody-mediated rejection.
Rafiq MA; de Boccardo G; Schröppel B; Bromberg JS; Sehgal V; Dinavahi R; Murphy B; Akalin E
Clin Transplant; 2009; 23(6):951-7. PubMed ID: 19624692
[TBL] [Abstract][Full Text] [Related]
3. Accelerated acute rejection in renal allograft.
Han DJ; Yoon HS; Lee HM
Transplant Proc; 1996 Jun; 28(3):1455. PubMed ID: 8658738
[No Abstract] [Full Text] [Related]
4. OKT3 treatment for steroid-resistant acute rejection in kidney transplantation.
Sevmis S; Emiroglu R; Karakayali F; Yagmurdur MC; Dalgic A; Moray G; Haberal M
Transplant Proc; 2005 Sep; 37(7):3016-8. PubMed ID: 16213290
[TBL] [Abstract][Full Text] [Related]
5. Late acute kidney transplant rejection: clinicopathological correlates and response to corticosteroid therapy.
Nair R; Agrawal N; Lebaeau M; Tuteja S; Chandran PK; Suneja M
Transplant Proc; 2009 Dec; 41(10):4150-3. PubMed ID: 20005357
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
7. Graft loss associated with late humoral rejection after renal transplantation.
Sun Q; Li L
Clin Transpl; 2006; ():521-5. PubMed ID: 18365417
[TBL] [Abstract][Full Text] [Related]
8. B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection.
Scheepstra C; Bemelman FJ; van der Loos C; Rowshani AT; van Donselaar-Van der Pant KA; Idu MM; ten Berge IJ; Florquin S
Transplantation; 2008 Sep; 86(6):772-8. PubMed ID: 18813100
[TBL] [Abstract][Full Text] [Related]
9. A case of accelerated acute rejection after ABO-compatible living unrelated kidney transplantation.
Matsuo N; Yamamoto H; Kobayashi A; Yamamoto I; Mitome J; Maruyama Y; Hayakawa H; Miyazaki Y; Utsunomiya Y; Hosoya T; Yamaguchi Y
Clin Transplant; 2009 Aug; 23 Suppl 20():23-6. PubMed ID: 19594591
[TBL] [Abstract][Full Text] [Related]
10. Impact of Banff borderline acute rejection among renal allograft recipients.
Matoza JR; Danguilan RA; Chicano S
Transplant Proc; 2008 Sep; 40(7):2303-6. PubMed ID: 18790219
[TBL] [Abstract][Full Text] [Related]
11. Relationship between early vs late acute rejection and onset of chronic rejection in kidney transplantation.
Basadonna GP; Matas AJ; Gillingham KJ; Payne WD; Dunn DL; Sutherland DE; Gores PF; Gruessner RW; Arrazola L; Najarian JS
Transplant Proc; 1993 Feb; 25(1 Pt 2):910-1. PubMed ID: 8442265
[No Abstract] [Full Text] [Related]
12. Clinical significance of slow recovery of graft function in living donor kidney transplantation.
Lee SY; Chung BH; Piao SG; Kang SH; Hyoung BJ; Jeon YJ; Hwang HS; Yoon HE; Choi BS; Kim JI; Moon IS; Kim YS; Choi YJ; Yang CW
Transplantation; 2010 Jul; 90(1):38-43. PubMed ID: 20531075
[TBL] [Abstract][Full Text] [Related]
13. Analysis of different staining techniques for c4d detection in renal allograft biopsies.
Ludovico-Martins H; Silva C; Teodoro WR; Martini Filho D; Noronha IL
Transplant Proc; 2009 Apr; 41(3):862-5. PubMed ID: 19376373
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2 receptor antibody reduces rejection rates and graft loss in live-donor kidney transplant recipients.
Lim WH; Chang SH; Chadban SJ; Campbell SB; Dent H; Russ GR; McDonald SP
Transplantation; 2009 Nov; 88(10):1208-13. PubMed ID: 19935375
[TBL] [Abstract][Full Text] [Related]
15. Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.
Everly MJ; Everly JJ; Susskind B; Brailey P; Arend LJ; Alloway RR; Roy-Chaudhury P; Govil A; Mogilishetty G; Rike AH; Cardi M; Wadih G; Tevar A; Woodle ES
Transplantation; 2008 Dec; 86(12):1754-61. PubMed ID: 19104417
[TBL] [Abstract][Full Text] [Related]
16. First year renal function as a predictor of kidney allograft outcome.
Resende L; Guerra J; Santana A; Mil-Homens C; Abreu F; da Costa AG
Transplant Proc; 2009 Apr; 41(3):846-8. PubMed ID: 19376368
[TBL] [Abstract][Full Text] [Related]
17. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy.
Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA
Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667
[TBL] [Abstract][Full Text] [Related]
18. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
19. Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5.
Cha RH; Yang SH; Kim HS; Kim SM; Park MH; Ha J; Kim YS
Nephrol Dial Transplant; 2009 Sep; 24(9):2919-25. PubMed ID: 19561149
[TBL] [Abstract][Full Text] [Related]
20. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
